Page 27 - Michael Erman News Today

By Michael Erman NEW YORK (Reuters) - A new COVID vaccine is due out next month, but health experts and analysts say it is likely to be coolly receive...

By Michael Erman NEW YORK (Reuters) - A new COVID vaccine is due out next month, but health experts and analysts say it is likely to be coolly receive...

Currently spreading COVID-19 variants such as EG.5, or Eris, do not represent a major shift and updated vaccines in September will offer protection, the director of the U.S. Centers for Disease...

(Reuters) - Currently spreading COVID-19 variants such as EG.5, or Eris, do not represent a major shift and updated vaccines in September will offer p...

-SK Bioscience is taking a roughly 7% stake in Novavax in lieu of some payment owed to the South Korean biotech company, giving the cash-strapped COVID-19 vaccine maker some breathing room....

(Reuters) - Gilead Sciences on Thursday reported lower second-quarter profit as costs from a legal settlement and sharply lower sales of its COVID-19 ...

Drugmakers are bracing for the US governments announcement of the 10 prescription medicines that will be subject to the first-ever price negotiations by the Medicare health program.

(Reuters) -Gilead Sciences on Thursday reported lower second-quarter profit as costs from a legal settlement and sharply lower sales of its COVID-19 treatment offset another strong performance by HIV drugs. The drugmaker raised its full-year revenue forecast, even as it trimmed its estimate for COVID antiviral Veklury due to lower pandemic-related hospitalizations. Gilead reported second-quarter earnings of $1.34 per share excluding items, on total revenue of $6.6 billion, down from $1.58 a sh...

Drugmakers are bracing for the U.S. governments announcement of the 10 prescription medicines that will be subject to the first-ever price negotiations by the Medicare health program that covers 66...

By Elissa Welle (Reuters) - Bausch + Lomb posted modestly better than expected second-quarter earnings on Wednesday after its new chief executive, ...